| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.3M | +9.5% |
| R&D Expense | $2.1M | +2613.0% |
| SG&A Expense | $16.3M | -58.2% |
| Operating Income | -$17.2M | +24.1% |
| Pre-tax Income | -$17.7M | +11.8% |
| Income Tax | $22K | +57.1% |
| Net Income | -$17.8M | +11.8% |
| EPS (Basic) | -$3.22 | +75.3% |
| EPS (Diluted) | -$3.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +339.7% |
| Inventory | $6.6M | -39.1% |
| Current Assets | $20.7M | -10.3% |
| Total Assets | $22.1M | -20.9% |
| Current Liabilities | $12.0M | -33.5% |
| Total Liabilities | $17.7M | -23.6% |
| Stockholders' Equity | $4.4M | -7.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.3M | +58.7% |
| Capital Expenditures | $10K | +100.0% |
| Investing Cash Flow | -$3K | -100.5% |
| Financing Cash Flow | $14.8M | +76.4% |
| Free Cash Flow | -$10.3M | +58.7% |
| +75.3% |